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Abstract
Background We report the determinants of serum levels
of vitamin D in a UK melanoma case–control study ben-
efitting from detailed exposure and genotyping data.
Methods Sun exposure, supplemental vitamin D, and
SNPs reported to be associated with serum levels were
assessed as predictors of a single serum 25-hydroxyvitamin
D3 measurement adjusted for season, age, sex, and body
mass index.
Results Adjusted analyses showed that vitamin D levels
were sub-optimal especially in the sun-sensitive individu-
als (-2.61 nmol/L, p = 0.03) and for inheritance of a
genetic variant in the GC gene coding for the vitamin
D-binding protein (-5.79 for heterozygotes versus wild
type, p = \0.0001). Higher levels were associated with
sun exposure at the weekend in summer (?4.71 nmol/L per
tertile, p = \0.0001), and on hot holidays (?4.17 nmol/L
per tertile, p = \0.0001). In smoothed scatter plots, vita-
min D levels of 60 nmol/L in the non-sun-sensitive indi-
viduals were achieved after an average 6 h/day summer
weekend sun exposure but not in the sun-sensitive indi-
viduals. Users of supplements had levels on average
11.0 nmol/L higher, p = \0.0001, and achieved optimal
levels irrespective of sun exposure.
Conclusions Sun exposure was associated with increased
vitamin D levels, but levels more than 60 nmol/L were
reached on average only in individuals reporting lengthy
exposure (C12 h/weekend). The sun-sensitive individuals
did not achieve optimal levels without supplementation,
which therefore should be considered for the majority of
populations living in a temperate climate and melanoma
patients in particular. Inherited variation in genes such as
GC is a strong factor, and carriers of variant alleles may
therefore require higher levels of supplementation.
Keywords Vitamin D  Sun exposure  Vitamin
D-binding protein  NADSYN1  DHCR7  GC  Sun
sensitivity  Supplementation  Insufficiency  CYP2R1
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Introduction
Vitamin D is important to human health [1–3], but sub-
optimal levels have been commonly reported [4] even in
hot countries such as Israel [5]. Blood levels are deter-
mined in part by sun exposure and pigmentation, so that
Electronic supplementary material The online version of this
article (doi:10.1007/s10552-011-9827-3) contains supplementary
material, which is available to authorized users.
J. R. Davies (&)  Y.-M. Chang  H. Snowden  M. Chan 
S. Leake  B. Karpavicius  S. Haynes  K. Kukalizch 
J. Randerson-Moor  F. Elliott  M. Harland 
D. T. Bishop  J. H. Barrett  J. A. Newton-Bishop
Section of Epidemiology and Biostatistics, Leeds Institute
of Molecular Medicine, University of Leeds, Cancer Genetics
Building, St James’s Hospital, Beckett Street,
Leeds LS9 7TF, UK
e-mail: J.R.Davies@leeds.ac.uk
J. Barth
Department of Clinical Biochemistry,
Leeds Teaching Hospitals Trust, Leeds, UK
P. A. Kanetsky
Department of Epidemiology and Biostatistics,
University of Pennsylvania, Philadelphia, PA, USA
123
Cancer Causes Control (2011) 22:1471–1482
DOI 10.1007/s10552-011-9827-3
darker-skinned people tend to have lower levels compared
with paler-skinned people living at the same latitude [6].
Recent evidence suggested, however, that within white-
skinned populations, the very fair surprisingly have lower
vitamin D levels, which may result from different behav-
iors in the sun [7, 8]. Vitamin D is fat soluble, and obesity
is associated with its lower levels in blood [9]. In many
populations levels change with age [9]. Most recently,
genome-wide association studies reported that a SNP in the
gene coding for the group-specific complement (vitamin
D-binding protein, GC) is associated with serum levels,
with additional probable involvement of genes involved in
the production of the active form of vitamin D [10, 11].
The approach to supplementation or recommended sun
exposure internationally remains controversial, especially
for those at increased risk of melanoma [12, 13]. The
benefits of sun exposure in terms of its effects on serum
vitamin D levels must be weighed against increased mel-
anoma risk. There are also concerns from studies on
prognosis in breast cancer patients [14] and risk of car-
diovascular disease [15] that the risk curve may be
U-shaped: that there may be increased risk of disease
progression associated with very high levels of serum
vitamin D.
We reported that lower serum vitamin D levels at
diagnosis are associated with thicker melanomas and
poorer outcome [16], so that understanding the determi-
nants of vitamin D levels in this population is important. In
this paper, we report the relationship between serum vita-
min D levels and variables postulated to determine those
levels, such as reported sun exposure, phenotype, dietary
supplementation and the following SNPs [10, 11]:
rs2282679, in the GC gene coding for vitamin D-binding
protein; rs10741657 in CYP2R1, the gene that encodes
vitamin D 25-hydroxylase, a key enzyme in the conversion
of vitamin D3 to an active vitamin D receptor ligand; and
rs7944926 and rs382925, intronic SNPs in NADSYN1,
which are in tight linkage disequilibrium (LD) with several
SNPs in the adjoining DHCR7 (7-dehydrocholesterol
reductase) gene (important to vitamin D metabolism in the
skin).
Materials and methods
A total of 960 population-ascertained incident melanoma
cases were recruited between September 2000 and
December 2005 [8, 17] in a geographically defined region
of the UK. Recruitment/blood sampling took place wher-
ever possible 3–6 months after diagnosis. A total of 513
population-ascertained controls were randomly invited
from individuals of the same sex and 5-year age group
by the family doctor of cases, and 174 sibling controls
participated, as described previously [18]. Studies were
approved by the UK Multi-Centre Research Ethics Com-
mittee (MREC) and the Patient Advisory Group (PIAG).
Informed consent was obtained from each participant.
Comprehensive sun exposure data were collected by
questionnaire and subsequent telephone interview [17]. An
initial postal questionnaire was completed by all partici-
pants (including a life-long residence calendar), and com-
prehensive sun exposure data were subsequently collected
by telephone, based upon that residence calendar. Data
were collected on weekday and weekend exposure (in
sunny and colder weather), and holiday sun exposure (at
low and higher latitudes) throughout life at 10-year inter-
vals and in the last year. Sun exposure variables for this
study were generated by using data collected on sun
exposure in the most recent year, which were classified into
thirds based upon their distribution in the population con-
trols. For variables where more than one-third of the pop-
ulation controls reported no sun exposure, the data were
classified into three groups: individuals with no sun
exposure, individuals with less than or equal to the median
sun exposure, and individuals with more than the median
sun exposure. Sex, natural hair color at age 18 years,
sunburn frequency, propensity to burn, ability to tan, skin
color of inside upper arm and freckling as a child [19] were
self-reported. A measure of deprivation (the Townsend
score) was derived from the subject’s current postcode
based on 2001 UK Census data [20]. Higher scores are
indicative of residence in more deprived communities.
Data on the intake of supplements containing vitamin D
were collected from cases (but not controls) and were
categorized as taking any regular supplementation or not.
Eye color and freckling scores were determined by
research nurses as described elsewhere [21].
25-Hydroxyvitamin D2/D3 levels were measured as
described elsewhere [16] in a single serum sample from 880
(92%) cases, 129 (74%) sibling controls and a subset (194,
38%) of population controls, taken around the time of data
collection. Controls were sampled in pre-defined time peri-
ods only (due to funding constraints). 25-Hydroxyvitamin
D2 and D3 levels were summed and henceforth referred to as
‘‘serum vitamin D level’’. The SNPs rs2282679, rs7944926,
rs10741657, and rs3829251 were genotyped in germ-
line DNA using the Taqman genotyping assays
C__26407519_10, C__12043682_10, C__2958430_10 and
C__27497388_10, respectively (Applied Biosystems, Foster
City, USA). See Supplementary Data.
Statistical methods
Multiple linear least squares regression models of the
determinants of vitamin D levels were fitted using the ‘‘lm’’
routine in R version 2.10.1, for the cases, the controls, and
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the cases and controls combined. Models were adjusted for
season, BMI, sex, age, Townsend score and case–control
status (where appropriate). The coefficient of determination
(r2) was calculated to measure the percentage of variance
in seasonally adjusted vitamin D levels explained by each
covariate, adjusted for the variables listed above. Supple-
mentation data were available for the cases only; a separate
multiple linear regression model was fitted in this subset
that additionally adjusted for vitamin D supplementation.
LOESS curves were fitted to illustrate the complex
effects of sun exposure, sun sensitivity, and supplementa-
tion on vitamin D levels and on the difference in adjusted
vitamin D levels attributable to SNPs. Further details of the
statistical methodology can be found in Supplementary
Data.
Results
The descriptive characteristics of participants are summa-
rized in Table 1 [8, 18, 22]. Cases had lower levels of
unadjusted vitamin D (crude mean level of 53.5 nmol/L)
than controls (crude mean levels of 57.3 and 60.1 nmol/L
for population and sibling controls). There was a statisti-
cally significant difference between cases and sibling
controls but not between cases and population controls
(Table 2). Overall suboptimal levels (\60 nmol/L) were
common, being observed in 63% of cases and 55% of
controls (data not shown).
Mean vitamin D levels are reported in Supplementary
Table 2. Vitamin D levels varied with season (Table 2).
Higher BMI was associated with lower serum vitamin D
Table 1 Mean vitamin D levels
and distribution of age, sex,
sensitivity, BMI, Townsend
score, and sunscreen usage in
cases, population controls, and
sibling controls
Vitamin D levels are reported
both stratified by season and
overall. Sun sensitivity is a
dichotomous measure generated
using factor analysis of six
correlated variables related to
sun sensitivity (see
Supplementary Data). Values
are given as absolute numbers
of individuals belonging to each
class and the percentage of the
total. For vitamin D levels, the
mean and standard deviation for
each group is given
* Differences between vitamin
D levels in cases, population,
and sibling controls tested using
a Kruskal–Wallis test
** Differences between groups
(cases, population, and sibling
controls) tested using a chi-
squared test
*** Differences between groups
(cases, population, and sibling
controls) tested using Fisher’s
exact test
Risk factor Cases Population controls Sibling controls p value
Vitamin D (nmol/L)
Mean (SD) 53.5 (21.9) 57.3 (19.4) 60.1 (25.2) 0.0008*
Mean vitamin D by season
1 (Jan–Mar) 45.5 (19.4) 52.3 (22.8) 46.6 (19.4) 0.3*
2 50.8 (20.4) 55.3 (16.2) 61.8 (28.5) 0.05*
3 65.3 (21.1) 61.0 (18.9) 65.6 (25.3) 0.6*
4 52.0 (21.3) 55.0 (20.2) 64.7 (22.2) 0.008*
Sex
Male 350 (39.8%) 78 (40.2%) 40 (31.0%) 0.2**
Female 530 (60.2%) 116 (59.8%) 89 (69.0%)
Age at diagnosis/interview
\40 196 (22.2%) 19 (9.8%) 25 (19.4%) \0.0001***
40–50 186 (21.1%) 27 (13.9%) 38 (29.5%)
50–60 213 (24.2%) 63 (32.5%) 29 (22.5%)
60–70 195 (22.2%) 42 (21.6%) 30 (23.2%)
[70 90 (10.2%) 43 (22.2%) 7 (5.4%)
Sun sensitivity score
Not sensitive 384 (43.8%) 111 (57.2%) 72 (56.3%) 0.0003**
Sensitive 493 (56.2%) 83 (42.8%) 56 (43.8%)
BMI
\18.5 8 (0.9%) 1 (0.5%) 2 (1.6%) 0.02***
18.5–25 345 (39.8%) 98 (50.5%) 54 (42.2%)
25–30 338 (39.0%) 74 (38.1%) 52 (40.6%)
[30 175 (20.2%) 21 (10.8%) 20 (15.6%)
Townsend
1 (lowest quartile) 149 (17.2%) 39 (20.4%) 29 (23.2%) 0.05**
2 246 (28.5%) 63 (33.0%) 38 (30.4%)
3 243 (28.1%) 59 (30.9%) 33 (26.4%)
4 (highest quartile) 226 (26.2%) 30 (15.7%) 25 (20.0%)
Recent sunscreen usage
None 326 (38.2%) 66 (34.0%) 60 (46.9%) 0.1**
SPF low 133 (15.6%) 26 (13.4%) 13 (10.2%)
SPF high 395 (46.3%) 102 (52.6%) 55 (43.0%)
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Table 2 Predictors of blood vitamin D concentration (nmol/L) in multiple linear regression models for cases, controls, and both cases and
controls combined
Factor Cases Controls Cases ? controls
n Estimate SE p value n Estimate SE p value Estimate SE p value
Season
1 (Jan to March-baseline) 239 0 53 0 0
2 183 5.56 1.98 0.005 71 9.00 3.89 0.02 6.41 1.76 0.0003
3 231 19.74 1.86 \0.0001 115 14.04 3.65 0.0001 18.0 1.64 \0.0001
4 197 5.83 1.94 0.003 76 9.67 3.85 0.01 6.94 1.73 \0.0001
BMI 850 -0.50 0.15 0.0007 315 -0.62 0.24 0.01 -0.52 0.12 \0.0001
Sex
Female (baseline) 512 0 197 0 0
Male 338 0.86 1.44 0.5 118 -1.00 2.60 0.7 0.69 1.25 0.6
Age (per year) 850 0.22 0.05 \0.0001 315 0.1 0.10 0.6 0.20 0.05 \0.0001
Townsend 850 -0.26 0.23 0.2 315 -0.46 0.49 0.3 -0.32 0.21 0.1
Case–control status
Case – – – – – – – – 0 (baseline)
Population control – – – – 191 0 (baseline) -0.33 1.69 0.9
Sibling control – – – – 124 4.87 2.59 0.06 5.73 1.98 0.004
Supplementation status
No (baseline) 552 0 – – – – – – –
Yes 246 10.6* 1.48 \0.0001 – – – – – – –
Sun sensitivity index
Non-sun-sensitive (baseline) 373 0 180 0 0
Sun sensitive 476 -2.74* 1.38 0.05 135 -1.71* 2.40 0.5 -2.61* 1.20 0.03
Nevus number
0–9 (baseline) 78 0 68 0 0
10–24 170 5.39* 2.74 0.05 95 4.35* 3.31 0.2 5.36* 2.09 0.01
[24 601 3.80* 2.41 0.1 131 8.89* 3.11 0.004 5.29* 1.84 0.004
Freckling total (%)
0–16.7 (baseline) 228 0 104 0 0
16.7–41.7 274 2.75* 1.77 0.1 88 6.23* 2.99 0.04 3.60* 1.53 0.02
[41.7 336 4.44* 1.70 0.009 97 10.94* 2.91 0.0002 5.88* 1.47 \0.0001
Freckling shoulders (%)
0–10 (baseline) 185 0 98 0 0
10–60 390 5.77* 1.75 0.001 113 7.18* 2.82 0.01 6.11* 1.48 \0.0001
[60 265 7.56* 1.88 \0.0001 80 13.37* 3.07 \0.0001 8.87* 1.60 \0.0001
Sunscreen usage
None (baseline) 318 0 125 0 0
SPF low 126 3.67* 2.10 0.08 39 11.75* 3.80 0.002 5.72* 1.85 0.002
SPF high 385 0.54* 1.51 0.7 151 3.61* 2.50 0.2 1.32* 1.30 0.3
Daily sun exposure (per tertile) 822 2.22** 0.86 0.01 308 2.94** 1.50 0.05 2.48** 0.75 0.0009
Weekend sun exposure
Overall (per tertile) 831 3.21** 0.88 0.0002 310 5.98** 1.49 \0.0001 3.97** 0.76 \0.0001
Cooler months (per tertile) 831 2.39** 0.83 0.004 311 3.19** 1.32 0.02 2.72** 0.70 0.0001
Warmer months (per tertile) 831 3.11** 0.90 0.0006 310 7.27** 1.55 \0.0001 4.17** 1.19 \0.0001
Holiday sun exposure
Overall (per tertile) 834 3.21** 0.88 0.0003 312 4.25** 1.44 0.003 3.56** 0.75 \0.0001
Lower than 45o (per tertile) 834 4.70** 0.82 \0.0001 312 3.99** 1.39 0.004 4.47** 1.18 \0.0001
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levels (adjusted estimate 0.52 units lower per unit of BMI,
p = \0.0001). There was no effect of sex on vitamin D
levels, but levels increased with age at diagnosis or inter-
view both overall and in cases. Table 2 also shows vitamin
D levels according to reported sun exposures for cases and
controls separately and for all pooled, adjusted for the
above factors. In the data from cases, we also adjusted for
reported vitamin D supplementation. In most instances,
little difference was seen in levels between cases and
controls, so that we report special cases where differences
were seen below. The strongest association with vitamin D
levels overall was with holiday exposure at low latitudes
(subjects adjusted mean levels increased by 9.1 units
between the lowest and highest group of exposure). There
was also strong association with average weekend exposure
in recent warmer months, with weaker correlations with
daily exposure and average holiday exposure. As reported
previously [8], individuals with greater sun sensitivity
overall had lower vitamin D levels (Table 2) and increased
freckling on the shoulders (presumed to be a marker of
greater habitual sun exposure in the fair-skinned) was
associated with higher levels. Indeed, a strong positive
association between freckling and higher reported levels of
sun exposure is seen (Table S1).
Use of low sun protection factor (SPF) sunscreen com-
pared with no use of sunscreen was associated with higher
serum levels in the total data set (adjusted estimate 5.72,
p = 0.002, Table 2), although there was no evidence of an
effect from high SPF sunscreen use.
To investigate the association between reported sun
exposure and vitamin D levels, we plotted reported recent
weekend sun exposure in warmer months against the
recorded single vitamin D measurement and fitted a
locally weighted scatterplot smoothing (LOESS) curve for
sun-sensitive individuals and a separate LOESS curve for
non-sun-sensitive individuals (Fig. 1). It can be seen that
in cases and controls considered together, the LOESS
curve describing the trend in vitamin D levels increased
to a plateau of just under 60 nmol/L in individuals
reporting an average of 5 h per day of weekend sun
exposure for non-sun-sensitive phenotypes. For individu-
als with sun-sensitive phenotypes, a lower plateau was
reached in individuals reporting an average of 6 h per day
of weekend sun exposure. In melanoma cases not taking
supplements, the plateau level of 60 nmol/L was reached
after a higher (6 h) average duration of exposure in those
with non-sun-sensitive phenotypes but not at all in the
sun-sensitive individuals. In those taking supplements, the
plateau of 60 nmol/L was reached irrespective of reported
sun exposure.
We looked at the effects of inherited variation in SNPs
in three genes reported to be associated with vitamin D
levels. Serum vitamin D levels were an estimated 5.79
units lower in those carrying 1 copy of rs2282679
(p = \0.0001) and 10.8 units lower in those carrying two
copies of the minor allele (p = \0.0001) compared with
homozygotes for the common allele (Table 2). Figure 2
illustrates the relationship between genotype, average
Table 2 continued
Factor Cases Controls Cases ? controls
n Estimate SE p value n Estimate SE p value Estimate SE p value
rs2282679 (GC)
TT (baseline) 426 0 158 0 0
GT 335 -5.58* 1.43 0.0001 138 -5.85* 2.44 0.01 -5.79* 1.24 \0.0001
GG 85 -12.57* 2.34 \0.0001 15 -2.09* 5.65 0.7 -10.80* 2.18 \0.0001
rs7944926 (NADSYN1)
GG (baseline) 493 0 178 0 0
AG 300 -3.65* 1.46 0.01 120 0.86* 2.47 0.7 -2.50* 1.26 0.05
AA 47 -4.60* 3.05 0.1 12 -10.9* 6.23 0.08 -6.00* 2.76 0.03
rs10741657 (CYP2R1)
GG (baseline) 287 0 125 0 0
AG 383 -3.47* 1.56 0.03 139 5.05* 2.56 0.04 -0.84* 1.34 0.5
AA 154 0.66* 2.00 0.7 45 9.03* 3.60 0.01 3.21* 1.76 0.07
Season, age, sex, BMI, case–control status (where appropriate), and Townsend score were included together in the multivariable model described
in the top part of the table
* Corrected for season, age, sex, case–control status (where appropriate), BMI, and Townsend score. Adjusted estimates used as a baseline the
estimated vitamin D level of a 54 year old case woman with a BMI score of 25, living in an area with a Townsend score of 0 (neither deprived
nor affluent), whose blood was sampled in winter. In the control group only, the baseline was calculated using the estimated vitamin D level of a
population control instead of a case
** Corrected for sun sensitivity status in addition to season, age, sex, case–control status (where appropriate), BMI, and Townsend score
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hours of weekend sun exposure in warmer months and
serum levels, and it is seen that the levels were related to
number of minor alleles inherited. Inheritance of the minor
allele of rs7944926 was also associated with lower serum
levels, although this only reached the 5% significance level
(adjusted estimates 2.50 lower, p = 0.05, for 1 copy and
6.0 lower, p = 0.03, for two copies, compared with no
copies). Inheritance of the minor allele of rs3829251,
which is in strong LD with rs7944926 (r2 = 0.49,
D0 = 0.97), showed a similar pattern of association (data
not shown). There was no clear evidence of association
between rs10741657 and serum levels in cases, or cases
and controls combined (adjusted estimate -0.84, p = 0.5,
for 1 copy of the minor allele, and 3.2, p = 0.07, for 2
copies, compared with none). However, there was some
evidence of an association in the controls (adjusted esti-
mate 5.05, p = 0.04 for 1 copy, 9.03, p = 0.01 for two
copies compared with none).
The presence of red hair and a tendency to burn in the
sun is largely a result of inherited variation in the gene
coding for the melanocortin 1 receptor (MC1R). No rela-
tionship was seen, however, between MC1R genotype and
serum vitamin D levels: for inheritance of two ‘‘R’’ vari-
ants which predict red hair most strongly or one ‘‘R’’
variant and one ‘‘r’’ variant, the estimate of the effect on
serum levels was 0.87, p = 0.7 (data not shown), compared
to inheritance of two wild-type alleles. No relationship was
seen for other combinations of ‘‘R’’ or ‘‘r’’ alleles.
We looked at the proportion of the variance in serum
vitamin D levels explained by the factors studied (Table 3)
because of potential clinical relevance of the results. Since
we only have supplementation data available for the cases,
our analysis is based largely on this subset of the data
although we show data additionally for controls. The fac-
tors that explained most of the variance in blood serum
levels in analyses adjusted for age, sex, gender, Townsend
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Fig. 1 Influence of sensitivity, supplementation and sun exposure on
vitamin D levels. For each subject recent weekend sun exposure in
warmer months is plotted against serum vitamin D levels by skin
sensitivity. Individuals who are sun-sensitive are in red, individuals
who are not sun-sensitive are in green. LOESS curves are plotted to
show how vitamin D levels vary with exposure for each group. In the
second panel, only cases who have not taken vitamin D supplements
are shown and in the third panel only cases who have taken vitamin D
supplements are shown
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score, season and case–control status were a measure of
total sun exposure summating weekend, daily and holiday
sun exposure (5.2%), dietary supplementation (6%) and
inherited genotype of the SNP coding for the vitamin
D-binding protein (4%). Of the different types of sun
exposure investigated, average holiday exposure at lower
latitudes explained the highest proportion (3.7%) of the
variance. On average, participants who were homozygous
for the variant allele in the gene coding for the vitamin
D-binding protein (rs2282679) had mean seasonally
adjusted serum vitamin D levels of 11.8 nmol/L lower than
those wild type for this gene (Table 4). When the data were
stratified by exposures shown to have a marked effect on
seasonally adjusted vitamin D levels, genotype for this
gene appeared to be most strongly associated with sup-
plementation. When participants were supplementing and
were wild type, their blood levels were 18.8 nmol/L on
average higher than those who were homozygous for the
rare variant. In those reporting on average of more than 5 h
in the sun on warm weekends, there was a mean difference
of 14.7 nmol/L in levels for homozygotes.
Discussion
Vitamin D is recognized to be important for health overall
[23, 24] and cancer prevention [3]. A recent meta-analysis
found an association between increased vitamin D intake
and decreased breast cancer risk [25]. Rhee et al. [26] also
recently reviewed studies of colorectal cancer and con-
cluded that prospective studies showed fairly uniform
reduction in risk in relation to higher vitamin D levels. We
have previously reported that serum vitamin D levels in
UK melanoma patients are low and that low vitamin D
levels are associated with both thicker tumors at diagnosis
and survival even when stratified for thickness [16]. It is
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Fig. 2 Influence of SNP genotype and sun exposure on vitamin D
levels. For each subject, recent weekend sun exposure in warmer
months is plotted against adjusted serum vitamin D levels for the
cases by presence of rare alleles for two SNPs under a dominant
model (0, 1?) or as three distinct genotypes (0, 1, 2); a rs2282679,
b rs7944926. LOESS curves are plotted to show how vitamin D levels
vary with exposure for each group. Vitamin D levels adjusted by
BMI, age, season the sample was taken, sex, case–control status,
vitamin D supplementation, and Townsend score
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important therefore to understand the determinants of
serum vitamin D levels in cancer patients.
A strength of this study is that uniquely we report
detailed sun exposure data in conjunction with measured
phenotypes of relevance to behaviors in the sun, dietary
supplementation and inherited SNPs postulated to influence
vitamin D levels. The main weaknesses of the study are a
lack of supplementation data and serum vitamin D mea-
sures in all of the controls. The data were collected from
melanoma patients and healthy individuals, and therefore,
the conclusions should be extrapolated to other populations
with caution.
The relationship between sun exposure and melanoma
risk is complex, in that sunburn and sunny holidays are
associated with increased risk of melanoma [27, 28], yet
occupational exposure appears to be associated with a
reduced risk [27]. Our recent observation that regular
weekend sun exposure was protective for melanoma [29] is
supportive of the view that vitamin D could have a role in
the prevention of melanoma. The observation reported
above that there was a statistically significant lower level of
vitamin D in cases at diagnosis than in their sibling controls
might be supportive of that view, but the data are based
upon sampling after diagnosis so must be interpreted with
caution.
Table 3 shows the proportion of variance in levels
explained by genotype and phenotype and examination of
the differences between cases and controls. It can be seen
that in controls, a greater proportion is explained by phe-
notypic variables such as nevus number than in cases, and a
Table 3 Proportion of variation explained (r2) by environmental and genetic determinants for seasonally adjusted levels of vitamin D
Factor Seasonally
adjusted only
r2 (%)
Adjusted
r2 (%)
Adjusted also
with supplementation
r2 (%)
Seasonally
adjusted only
r2 (%)
Adjusted
r2 (%)
Seasonally
adjusted only
r2 (%)
Adjusted
r2 (%)
Cases Controls Cases ? controls
BMI 1.0 – – 2.1 – 1.3 –
Sex 0.06 – – 0.2 – 0.02 –
Age (per year) 2.1 – – 0.03 – 1.4 –
Townsend 0.5 – – 0.3 – 0.6 –
Case–control status – – – 1.0 – 0.7 –
Supplementation 7.0 6.0 – – – –
Sun sensitivity index 0.6 0.5 0.9 0.3 0.2 0.6 0.4
Nevus number 0.4 0.5 0.4 3.2 2.8 0.3 0.8
Freckling total (%) 0.9 0.8 0.9 4.0 4.8 1.3 1.4
Freckling shoulders (%) 1.9 2.0 1.9 5.7 6.2 2.4 2.7
Sunscreen usage 0.5 0.4 0.3 3.5 3.0 0.9 0.8
Sun exposure** – 5.2 5.4 – 8.7 – 6.0
Daily sun exposure* 0.4 0.8 1.0 1.3 1.2 0.6 1.0
Weekend sun exposure*
Overall* 2.3 1.7 2.1 5.1 5.1 3.2 2.4
Weekend exposure cooler months* 1.4 1.1 1.1 1.7 1.9 1.7 1.4
Weekend exposure warmer months* 2.0 1.5 2.0 6.7 6.7 3.1 2.5
Holiday exposure*
Overall* 2.0 1.6 1.8 2.3 2.7 2.3 2.0
Holiday exposure lower than 45o* 3.6 3.7 3.6 2.4 2.5 3.2 3.3
rs_2282679 3.9 4.0 4.9 2.6 1.8 3.3 3.1
rs_7944926 0.6 0.9 1.0 1.2 1.1 0.5 0.6
rs_10741657 0.7 0.9 0.8 2.3 2.4 0.4 0.5
Adjusted models were corrected for age, sex, case–control status, vitamin D supplementation(where appropriate), BMI, and Townsend score
* Corrected for sun sensitivity status in addition to season, age, sex, vitamin D supplementation, BMI, and Townsend score in multivariable
models
** Model includes daily sun exposure, weekend sun exposure in warmer months, weekend sun exposure in cooler months, holiday sun exposure
and holiday sun exposure at low latitudes and is also corrected for sun sensitivity
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greater proportion by weekend sun exposure than in cases.
We previously reported that sunburn (which was most
associated with sunny holidays) was a risk factor for
melanoma, yet weekend sun exposure was protective [29].
So the difference in the effect of weekend sun exposure on
vitamin D levels between cases and controls was expected.
The significance of the other differences including nevus
count is, however, difficult to interpret especially as we
cannot allow for the effects of supplementation in the
controls, and the total number of controls was much lower
than cases, so that the relatively small differences between
cases and controls could simply be a function of sample
size.
It is recognized that blood levels of vitamin D are sub-
optimal in many populations, even surprisingly in Australia
[30]. Our data show that in the UK, obesity (BMI [ 30) is
associated with lower levels of vitamin D, as is widely
reported. We also showed that increasing age was associ-
ated with higher levels, although older age groups in other
studies from around the world have been reported to have
lower levels of vitamin D [31]. Indeed higher levels of
supplementation are commonly recommended for older
age groups [32]. Some proportion of the reported lower
vitamin D levels in the elderly in other studies may be
related to reduced mobility and therefore reduced access to
sun exposure [4], and we would not have identified this
sub-population in our study of essentially mobile recruits.
A previous UK study in healthy female twins also showed
increased levels with age, although this did not reach sta-
tistical significance [7]. In this study, therefore, we have
shown that in the UK individuals who are not housebound
do not appear to show a reduction in vitamin D levels with
age, and indeed, there was evidence of the opposite.
Sun exposure explained the greatest proportion of the
variance in levels in cases as expected. In a large study
called ‘‘Expolis’’ [33], in which time spent outdoors was
estimated in randomly selected people living in seven
European countries, the mean and median times per day
outdoors was 1.68 and 1.38 h, respectively. This suggests
that on average, the duration spent outside is less than that
shown in our study to be associated with optimal levels of
vitamin D (around 6 h/day weekend exposure in warmer
months). Our data are therefore consistent with published
data suggesting that vitamin D levels are consistently low
in many studies worldwide, that is, our data are supportive
of the view that the majority of the cases and controls in
this study did not have sufficient sun exposure to result in
optimal levels in the blood. It is of note moreover that for
sun-sensitive people, there was a weaker relationship
between weekend sun exposure and vitamin D levels
(Fig. 1), and that overall sun sensitivity was associated
with lower vitamin D levels which is consistent with pre-
vious studies [7, 34]. The lower levels in the most sun-
sensitive individuals are postulated to be behavioral, and
indeed a lower proportion of the variance in levels was
associated with holiday sun exposure (1.6% compared with
2.6% in the non-sensitive, data not shown). Although
sunny holidays, particularly at low latitudes, were associ-
ated with higher vitamin D levels in controls, overall the
association was weaker. One interpretation of the data
presented in Table 3 is that melanoma patients achieved
more vitamin D synthesis as a result of holiday sun
exposure than controls, who achieved more as regular
weekend sun exposure, and this indeed may reflect the
etiological relationship between holiday sun exposure and
melanoma risk.
Table 4 Mean seasonally
adjusted vitamin D levels
stratified by rs2282679 (GC
protein) genotype
Inheritance of less common
variants in rs 2282679 (vitamin
D-binding protein) is associated
with lower levels of vitamin D.
Here we show the effects of
exposures moderating
seasonally adjusted vitamin D
level and the differences in
levels achieved as a result of
those exposures by genotype.
The adjusted estimate assumes
that blood was drawn in winter
Mean vitamin D level (SD) TT GT GG
49.6 (21.4) 43.7 (20.2) 37.8 (16.8)
Weekend exposure in warmer months (h/day)
B3 44.7 (20.8) 40.0 (19.5) 34.7 (14.4)
3–5 51.3 (20.8) 45.6 (20.5) 40.2 (18.7)
[5 54.2 (22.4) 48.1 (19.6) 39.5 (18.7)
Holiday exposure \45N (h)
0 47.2 (21.1) 37.9 (18.0) 35.5 (14.8)
0–87.5 49.8 (21.3) 45.8 (20.0) 41.5 (17.8)
[87.5 52.8 (21.7) 52.3 (20.8) 36.7 (18.9)
Supplementation
No 44.9 (20.1) 38.9 (19.0) 33.9 (14.5)
Yes 56.7 (20.3) 52.4 (19.1) 37.9 (16.4)
Sensitivity
Non-sun-sensitive 50.8 (21.7) 45.6 (20.4) 41.7 (17.1)
Sun-sensitive 48.5 (21.2) 41.9 (19.9) 33.9 (15.8)
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We found no evidence that regular use of high SPF
sunscreen reduces vitamin D levels as reported by other
studies (reviewed by Springbett [35]). Springbett’s con-
clusion was that although sunscreens have the potential to
reduce vitamin D synthesis, in practice they do not. In the
overall analysis, however, use of low SPF sunscreen did
seem to be associated with higher levels. We postulated
that the higher vitamin D levels might have resulted from
participants using low SPF sunscreen in conjunction with
sun-seeking behaviors. We see evidence to support this in
our data; the median hours/year of sun exposure on holiday
increased from 70 in those who used no sunscreen or high
SPF sunscreen to 84 in low SPF users (data not shown). In
the case-only comparison, however, this effect disappeared
so that the significance of this effect remains unclear.
A strong predictor of serum levels was inheritance of the
SNP in the gene coding for vitamin D-binding protein,
(GC) rs2282679. The data suggest an additive effect on
levels, and Fig. 2 shows evidence that sun exposure
increases levels consistently, but the genotype influences
blood levels reached. This supports evidence in similar
previous studies suggesting an association between variants
in the gene coding for vitamin D-binding protein and serum
vitamin D levels [10, 11, 36–39]. Recent individual gen-
ome-wide association studies have associated these SNPs
with serum vitamin D levels [10, 11], and our results
provide independent confirmation that variation in the
NADSYN1/DHCR7 region may influence vitamin D levels.
We showed no relationship between the inheritance of
variation at CYP2R1 rs10741657 and vitamin D levels in
cases; however, we did see some evidence of association in
controls. SNPs at this locus have been inconsistently
associated with serum levels [10, 11, 40]. Carriers of two
minor alleles of rs2282679 (8% in this study overall) had
levels on average 11.8 nmol/L lower than wild-type
homozygotes. This suggests that people will vary in how
readily they respond to sun exposure and will need dif-
ferent levels of supplementation to obtain optimal serum
levels.
The optimal level of vitamin D remains unclear, but
levels of around 60–75 nmol/L are associated with a pla-
teau in parathyroid hormone level [41], with reduced risk
of cardiovascular disease [15] and optimal survival from
breast cancer [14]. Taking a level of at least 60 nmol/L as
optimal, our data suggest that these levels are only
achieved, on average, by those with sun-sensitive pheno-
types, when they take supplements. It is hypothesized that
these very fair-skinned people were unable to sustain
enough sun exposure to synthesize sufficient vitamin D
while protecting themselves from sunburn. Optimal levels
were reached in a much higher proportion of individuals,
irrespective of phenotype, if they took supplements rather
than relying on sun exposure alone. There was moreover
little evidence that supplement takers had excessively high
levels even if they had high sun exposure (Fig. 1).
In summary, we have shown that regular weekend and
holiday sun exposure is associated with higher blood levels
of vitamin D although optimal levels appeared to occur as a
result of weekend exposure only when the participants
reported exposure in the order of 6 h/day, so that overall
the majority of participants in the study had sub-optimal
levels. Photobiology studies have suggested that compar-
atively little sun exposure is sufficient to synthesize enough
vitamin D, but the high prevalence of measured insuffi-
ciency in other studies suggests that in practice, this is an
underestimate and this study would support that theory.
Diffey recently also argued that the nature of casual sun
exposure is insufficient to maintain adequate vitamin D in
the modern world [42], and a UK photobiology study
recently concluded that supplementation would have to be
considered if year-round levels of vitamin D in excess of
60 nmol/L were required [43]. Pros and cons of sun
exposure versus supplementation have been argued and
were eloquently discussed by Lucas and Ponsonby [44],
but in this study supplementation was associated with
higher blood levels irrespective of sun exposure, and our
data support its use especially in sun-sensitive individuals
and melanoma patients. The marked relationship between
inherited variation in the gene coding for vitamin D-bind-
ing protein, high BMI and blood levels suggests that some
individuals will find it more difficult to achieve optimal
levels than others and argues for measurement of serum
levels after supplementation in the deficient.
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